Markets:

Overview

News

Currencies

International

Treasuries

Onconova Therapeutics, Inc. - Common Stock (NQ:ONTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Onconova Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 15, 2022

Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out...

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Recap: Onconova Therapeutics Q1 Earnings ↗

May 11, 2022

Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Why PlayAGS Shares Are Trading Lower By Over 15%; Here Are 33 Stocks Moving Premarket ↗

November 15, 2022

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Looking Into Onconova Therapeutics's Return On Capital Employed ↗

September 07, 2022

According to data from Benzinga Pro, during Q2, Onconova Therapeutics's (NASDAQ:ONTX) reported sales totaled $57 thousand. Despite a 2.38% increase in earnings, the company posted a loss of $4.02...

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

53 Stocks Moving In Thursday's Mid-Day Session ↗

June 02, 2022

Gainers

Via Benzinga

Onconova Therapeutics Earnings Preview ↗

May 10, 2022

Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Recap: Onconova Therapeutics Q4 Earnings ↗

March 17, 2022

Onconova Therapeutics (NASDAQ:ONTX) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

Earnings Outlook For Onconova Therapeutics ↗

March 16, 2022

Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 ↗

March 01, 2022

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 15, 2021

Gainers Calliditas Therapeutics (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 07, 2021

Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion....

Via Benzinga

Recap: Onconova Therapeutics Q3 Earnings ↗

November 11, 2021

Onconova Therapeutics (NASDAQ:ONTX) reported its Q3 earnings results on Thursday, November 11, 2021 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

Onconova Therapeutics Earnings Perspective: Return On Capital Employed ↗

November 11, 2021

Benzinga Pro data, Onconova Therapeutics (NASDAQ:ONTX) reported Q2 sales of $57.00 thousand. Earnings fell to a loss of $4.64 million, resulting in a 13.35% decrease from last...

Via Benzinga

Earnings Outlook For Onconova Therapeutics ↗

November 10, 2021

Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Thursday, 2021-11-11. Here's what investors need to know before the announcement....

Via Benzinga

Onconova Therapeutics's Return On Capital Employed Overview ↗

September 30, 2021

Onconova Therapeutics (NASDAQ:ONTX) brought in sales totaling $57.00 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 13.35%, resulting...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

48 Biggest Movers From Friday ↗

September 27, 2021

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday. Clearwater Analytics Holdings, Inc. (NYSE: CWAN) surged 40.9% to settle at $25.37...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 40 Points; Meredith Shares Spike Higher ↗

September 24, 2021

Toward the end of trading Friday, the Dow traded up 0.12% to 34,805 while the NASDAQ fell 0.13% to 15,033.02. The S&P also rose, gaining 0.12% to 4,454.25. The U.S. has the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 24, 2021

Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume for Molecular Templates's stock is 937.9K as...

Via Benzinga

Mid-Day Market Update: Aehr Test Systems Surges Following Q1 Results; Onconova Therapeutics Shares Slide ↗

September 24, 2021

Midway through trading Friday, the Dow traded down 0.03% to 34,753.87 while the NASDAQ fell 0.45% to 14,984.38. The S&P also fell, dropping 0.10% to 4,444.74. The U.S. has the...

Via Benzinga

Topics Stocks

34 Stocks Moving In Friday's Mid-Day Session ↗

September 24, 2021

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares jumped 76.2% to $6.08. Unique Fabricating, Inc. (NASDAQ: UFAB) jumped 37.7% to $3.47. Form 4 filings from late Thursday...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Onconova Therapeutics, Inc. - Common Stock (NQ:ONTX)

Headline News about Onconova Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today